Combined endostatin/sFlt-1 antiangiogeni
✍
Florian Graepler; Barbara Verbeek; Tilmann Graeter; Irina Smirnow; Hwai Loong Ko
📂
Article
📅
2005
🏛
John Wiley and Sons
🌐
English
⚖ 835 KB
Hepatocellular carcinoma (HCC) is regarded as a suitable target for antiangiogenic strategies. However, antiangiogenic agents aimed at single targets can be neutralized by upregulation of other proangiogenic factors. Therefore, combined approaches addressing at least two angiogenic targets should be